Showing results (81-90 of 86) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The Lancet. Infectious Diseases|January 18, 2024
Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort studyAdedapo O Bashorun, Larry Kotei, Ousubie Jawla, et al.Lancet (London, England)|February 25, 2024
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trialMagnus Ochoge, Ahmed Cherno Futa, Ama Umesi, et al.Plos Pathogens|August 23, 2012
Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infectionUrsula Neu, Holger Hengel, Bärbel S Blaum, et al.The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.Science Advances|June 3, 2026
Am80-lipid nanoparticles serve as an enteric mucosal adjuvant following parenteral immunization with inactivated polio vaccineBehnaz Eshaghi, Erika Yan Wang, Sevinj Mursalova, et al.Cell|July 26, 2016
Structure and Function Analysis of an Antibody Recognizing All Influenza A SubtypesNicole L Kallewaard, Davide Corti, Patrick J Collins, et al.Pageof 9